[Skip to Content]
[Skip to Content Landing]
Other Articles
July 31, 1937

The Chemical Laboratory

JAMA. 1937;109(5):358. doi:10.1001/jama.1937.02780310036010
Abstract

EXAMINATION OF CERTAIN AMERICAN BRANDS OF SULFANILAMIDE  The history of the introduction of para-amino-benzene sulfonamide in therapeutics was recounted in The Journal, January 2.It was apparently first introduced in the United States under the proprietary name "Prontylin." As this product was not, and could not be, protected by letters patent, and as other firms were privileged to make it, the Council on Pharmacy and Chemistry was approached for a nonproprietary name. The announcement of the term "Sulfanilamide" was made in The Journal, April 17. A report of the Council on Pharmacy and Chemistry on sulfanilamide appeared subsequently in The Journal, May 29.A number of firms have submitted brands of sulfanilamide for the Council's consideration with a view to acceptance and inclusion in New and Nonofficial Remedies. The Council in turn asked the A. M. A. Chemical Laboratory to examine theproduct and elaborate standards for identity and purity. At the time of this report the following firms had presented brands

First Page Preview View Large
First page PDF preview
First page PDF preview
×